1 Market Overview

1.1 Product Overview and Scope of siRNA Drugs

1.2 Classification of siRNA Drugs by Type

1.2.1 Overview: Global siRNA Drugs Market Size by Type: 2022 Versus 2028

1.2.2 Global siRNA Drugs Revenue Market Share by Type in 2029

1.2.3 Without GalNAc-conjugated

1.2.4 With GalNAc-conjugated

1.3 Global siRNA Drugs Market by Application

1.3.1 Overview: Global siRNA Drugs Market Size by Application: 2023 Versus 2029

1.3.2 Genetic Disease

1.3.3 Cancers

1.3.4 Other

1.4 Global siRNA Drugs Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 siRNA Drugs Market Drivers

1.5.2 siRNA Drugs Market Restraints

1.5.3 siRNA Drugs Trends Analysis

2 Company Profiles

2.1 Alnylam

2.1.1 Alnylam Details

2.1.2 Alnylam Major Business

2.1.3 Alnylam siRNA Drugs Product and Solutions

2.1.4 Alnylam Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis siRNA Drugs Product and Solutions

2.2.4 Novartis Recent Developments and Future Plans

2.3 Sirnaomics

2.3.1 Sirnaomics Details

2.3.2 Sirnaomics Major Business

2.3.3 Sirnaomics siRNA Drugs Product and Solutions

2.3.4 Sirnaomics Recent Developments and Future Plans

2.4 Ribo Life Science

2.4.1 Ribo Life Science Details

2.4.2 Ribo Life Science Major Business

2.4.3 Ribo Life Science siRNA Drugs Product and Solutions

2.4.4 Ribo Life Science Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global siRNA Drugs Revenue and Share by Players (2023 & 2029)

3.2 siRNA Drugs Players Head Office, Products and Services Provided

3.3 siRNA Drugs Mergers & Acquisitions

3.4 siRNA Drugs New Entrants and Expansion Plans

4 Global siRNA Drugs Forecast by Region

4.1 Global siRNA Drugs Market Size by Region: 2023 VS 2029

4.2 Global siRNA Drugs Market Size by Region, (2023-2029)

4.3 North America

4.3.1 Key Companies of siRNA Drugs in North America

4.3.2 Current Situation and Forecast of siRNA Drugs in North America

4.3.3 North America siRNA Drugs Market Size and Prospect (2023-2029)

4.4 Europe

4.4.1 Key Companies of siRNA Drugs in Europe

4.4.2 Current Situation and Forecast of siRNA Drugs in Europe

4.4.3 Europe siRNA Drugs Market Size and Prospect (2023-2029)

4.5 Asia-Pacific

4.5.1 Key Companies of siRNA Drugs in Asia-Pacific

4.5.2 Current Situation and Forecast of siRNA Drugs in Asia-Pacific

4.5.3 Asia-Pacific siRNA Drugs Market Size and Prospect (2023-2029)

4.5.4 China

4.5.5 Japan

4.5.6 South Korea

4.6 South America

4.6.1 Key Companies of siRNA Drugs in South America

4.6.2 Current Situation and Forecast of siRNA Drugs in South America

4.6.3 South America siRNA Drugs Market Size and Prospect (2023-2029)

4.7 Middle East & Africa

4.7.1 Key Companies of siRNA Drugs in Middle East & Africa

4.7.2 Current Situation and Forecast of siRNA Drugs in Middle East & Africa

4.7.3 Middle East & Africa siRNA Drugs Market Size and Prospect (2023-2029)

5 Market Size Segment by Type

5.1 Global siRNA Drugs Market Forecast by Type (2023-2029)

5.2 Global siRNA Drugs Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application

6.1 Global siRNA Drugs Market Forecast by Application (2023-2029)

6.2 Global siRNA Drugs Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global siRNA Drugs Revenue by Type, (USD Million), 2023 VS 2029

Table 2. Global siRNA Drugs Revenue by Application, (USD Million), 2023 VS 2029

Table 3. Alnylam Corporate Information, Head Office, and Major Competitors

Table 4. Alnylam Major Business

Table 5. Alnylam siRNA Drugs Product and Solutions

Table 6. Novartis Corporate Information, Head Office, and Major Competitors

Table 7. Novartis Major Business

Table 8. Novartis siRNA Drugs Product and Solutions

Table 9. Sirnaomics Corporate Information, Head Office, and Major Competitors

Table 10. Sirnaomics Major Business

Table 11. Sirnaomics siRNA Drugs Product and Solutions

Table 12. Ribo Life Science Corporate Information, Head Office, and Major Competitors

Table 13. Ribo Life Science Major Business

Table 14. Ribo Life Science siRNA Drugs Product and Solutions

Table 15. Global siRNA Drugs Revenue (USD Million) by Players (2023 & 2029)

Table 16. Global siRNA Drugs Revenue Share by Players (2023 & 2029)

Table 17. siRNA Drugs Players Head Office, Products and Services Provided

Table 18. siRNA Drugs Mergers & Acquisitions in the Past Five Years

Table 19. siRNA Drugs New Entrants and Expansion Plans

Table 20. Global Market siRNA Drugs Revenue (USD Million) Comparison by Region (2023 VS 2029)

Table 21. Global siRNA Drugs Revenue Market Share by Region (2023-2029)

Table 22. Key Companies of siRNA Drugs in North America

Table 23. Current Situation and Forecast of siRNA Drugs in North America

Table 24. Key Companies of siRNA Drugs in Europe

Table 25. Current Situation and Forecast of siRNA Drugs in Europe

Table 26. Key Companies of siRNA Drugs in Asia-Pacific

Table 27. Current Situation and Forecast of siRNA Drugs in Asia-Pacific

Table 28. Key Companies of siRNA Drugs in China

Table 29. Key Companies of siRNA Drugs in Japan

Table 30. Key Companies of siRNA Drugs in South Korea

Table 31. Key Companies of siRNA Drugs in South America

Table 32. Current Situation and Forecast of siRNA Drugs in South America

Table 33. Key Companies of siRNA Drugs in Middle East & Africa

Table 34. Current Situation and Forecast of siRNA Drugs in Middle East & Africa

Table 35. Global siRNA Drugs Revenue Forecast by Type (2023-2029)

Table 36. Global siRNA Drugs Revenue Forecast by Application (2023-2029)

List of Figures

Figure 1. siRNA Drugs Picture

Figure 2. Global siRNA Drugs Revenue Market Share by Type in 2029

Figure 3. Without GalNAc-conjugated

Figure 4. With GalNAc-conjugated

Figure 5. siRNA Drugs Revenue Market Share by Application in 2029

Figure 6. Genetic Disease Picture

Figure 7. Cancers Picture

Figure 8. Other Picture

Figure 9. Global siRNA Drugs Market Size, (USD Million): 2023 VS 2029

Figure 10. Global siRNA Drugs Revenue and Forecast (2023-2029) & (USD Million)

Figure 11. siRNA Drugs Market Drivers

Figure 12. siRNA Drugs Market Restraints

Figure 13. siRNA Drugs Market Trends

Figure 14. Alnylam Recent Developments and Future Plans

Figure 15. Novartis Recent Developments and Future Plans

Figure 16. Sirnaomics Recent Developments and Future Plans

Figure 17. Ribo Life Science Recent Developments and Future Plans

Figure 18. Global siRNA Drugs Revenue Market Share by Region (2023-2029)

Figure 19. Global siRNA Drugs Revenue Market Share by Region in 2029

Figure 20. North America siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 21. Europe siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 22. Asia-Pacific siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 23. South America siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 24. Middle East & Africa siRNA Drugs Revenue (USD Million) and Growth Rate (2023-2029)

Figure 25. Global siRNA Drugs Market Share Forecast by Type (2023-2029)

Figure 26. Global siRNA Drugs Market Share Forecast by Application (2023-2029)

Figure 27. Methodology

Figure 28. Research Process and Data Source